# FDA Inspection 1171283 - e+ Oncologics Louisiana, L.L.C. - March 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/d37a1e4e-2f7d-4626-8f89-c73ff42b9ee5
Source feed: FDA_Inspections

> FDA Inspection 1171283 for e+ Oncologics Louisiana, L.L.C. on March 28, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171283
- Company Name: e+ Oncologics Louisiana, L.L.C.
- Inspection Date: 2022-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1244909 - 2024-07-09](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/a271dcc0-9c73-4cb4-a50a-f38880173356)
- [FDA Inspection 1171283 - 2022-03-28](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/e2c5bdae-ef32-4608-a312-bdcb1f222b44)
- [FDA Inspection 1044991 - 2018-01-18](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/ccc75662-3ea6-4fab-a556-cfce3d7bdd83)
- [FDA Inspection 945916 - 2015-10-21](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/c0b875b9-70aa-4bcf-898e-9fe7583a3bd5)
- [FDA Inspection 878411 - 2014-05-13](https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/1f3f7438-2d2f-43f7-bae0-783a29a19c5a)

Company: https://www.keypedia.com/companies/e-oncologics-louisiana-llc/ebf8bd7e-df16-4970-85c1-4603e143703f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d